Retail Community Pharmacist Wages Declined from 2012 to 2022
Drug Topics
APRIL 30, 2024
Researchers addressed the wage gaps in specific pharmacy settings in relation to big chain retail pharmacy mergers.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Drug Topics
APRIL 30, 2024
Researchers addressed the wage gaps in specific pharmacy settings in relation to big chain retail pharmacy mergers.
Pharmaceutical Technology
JANUARY 17, 2024
The EC has granted orphan drug designation (ODD) for Precigen's PRGN-2012 aimed at treating recurrent respiratory papillomatosis (RRP).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 27, 2023
Indeed, Initial Public Offerings (IPOs) raised just £28 million – the worst annual haul since 2012 – and, during the entirety of last year, UK biotech raised just £1.8 The post UK biotech sees worst funding downturn since 2012 appeared first on. billion, way down from £4.5 billion in 2021. billion raised.
Outsourcing Pharma
MARCH 20, 2023
Despite diversity being spoken about more than ever before, research discovers clinical trials are less representative of the US population compared to a decade prior.
STAT
NOVEMBER 22, 2024
Since 2012, I’ve been blogging and on social media, connecting with the lung cancer community and learning/sharing developments in cancer research. I’ve been living with and communicating about lung cancer for over 13 years.
PhRMA
DECEMBER 15, 2022
In this case, the Berkeley Research Group (BRG) found that nearly 36% of all Medicare Part B therapy sales occurred at 340B hospitals in 2021 , up nearly 17 percentage points since 2012, meaning care is moving from physician offices and non-340B hospitals to 340B hospitals.
Fierce Pharma
JULY 8, 2024
The traditional approvals follow initial accelerated approvals granted by the FDA in 2012 and the European Commission in 2014. It took many years, but Johnson & Johnson’s tuberculosis med Sirturo can finally claim full approvals in the U.S. and Europe following initial conditional nods. |
STAT
OCTOBER 31, 2024
There’s Jennifer Doudna and Emmanuelle Charpentier, the Nobel-prize winning authors of a 2012 Science paper that detailed how CRISPR-Cas9 worked in bacterial cells. If you’ve been following the biomedical revolution now thoroughly underway, then you likely know the names of the scientific luminaries who kicked it all off.
STAT
SEPTEMBER 20, 2024
In 2012, British journalist Michael Mosley sparked a global trend with his BBC documentary, “Eat, Fast and Live Longer.” ” Seeking a simple way to get healthy without growing his to-do list, Mosley discovered fasting. It’s all a matter of what you eat.
STAT
AUGUST 16, 2024
Natterson-Horowitz is a cardiologist, psychiatrist, and evolutionary biologist who co-authored the 2012 book “ Zoobiquity: The Astonishing Connection Between Human and Animal Health.”
STAT
JULY 2, 2024
The Food and Drug Administration’s rare pediatric disease priority review voucher program , which has been providing incentives for lifesaving innovations since 2012, is doomed to disappear unless Congress reauthorizes it before the end of September. I have data showing it works.
Drug Topics
APRIL 5, 2023
Data suggest confirmatory trials conducted for drugs granted accelerated approval by the FDA have taken over 3 years on average to complete since 2012.
Pharmaceutical Technology
SEPTEMBER 4, 2024
Between 2012 and 2021, outsourcing propensity for FDA NDA injectables approvals averaged 40%, according to GlobalData’s Contract Injectable Packaging Trends…
STAT
MAY 8, 2024
was mistakenly diagnosed with a brain tumor after scans picked up abnormalities that turned out to be “caused by a worm that got into my brain and ate a portion of it and then died,” he reportedly said in a 2012 deposition reviewed by The New York Times. Kennedy Jr. Read the rest…
STAT
AUGUST 16, 2024
Natterson-Horowitz is a cardiologist, psychiatrist, and evolutionary biologist who co-authored the 2012 book “ Zoobiquity: The Astonishing Connection Between Human and Animal Health.”
Fierce Pharma
NOVEMBER 21, 2023
The lawsuit further accuses the companies of manipulating quality-control testing from 2012 to 2018 to ensure samples received passing grades. . | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR.
STAT
APRIL 24, 2024
death certificate data from 1999 through 2021, revealing a steady drop in deaths until 2012, when rates plateaued, then began to rise steadily, and accelerated upward once the Covid-19 pandemic arrived. The concerning conclusion comes as newer medications are raising hopes for better outcomes in the years to come.
STAT
NOVEMBER 7, 2023
The number of cases of congenital syphilis in 2022 was more than 10 times the number recorded in 2012, the agency said, noting that most of the 3,761 cases reported in 2022 could have been averted, if the babies’ mothers had been adequately tested and treated. Read the rest…
STAT
OCTOBER 1, 2024
Performed by researchers at Johns Hopkins University, the study found that between 2012 and 2019, 8.8% . Now, a data analysis commissioned by STAT shows that the rate of postpartum sterilization is significantly higher in Americans with sickle cell disease than in those without. of births to unaffected mothers did.
STAT
SEPTEMBER 8, 2023
Since 2012, comedian and filmmaker Lauren Miller Rogen and her husband, actor and comedian Seth Rogen, have used humor to help raise awareness for Alzheimer’s disease and funds for at-home caregiving through their nonprofit Hilarity for Charity. Alzheimer’s isn’t funny.
The Guardian - Pharmaceutical Industry
MARCH 10, 2024
The latest award brings to £137m the amount he has earned since joining in 2012. a year earlier. While it drew the anger of corporate governance experts, Soriot’s generous payout was just a fraction of the sums his counterparts at the biggest US companies take home.
Pharmacy Times
AUGUST 17, 2022
Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.
Pharmaceutical Technology
AUGUST 7, 2024
Precigen also plans to raise $30m to focus on advancing its recurrent respiratory papillomatosis (RRP) candidate PRGN-2012.
STAT
OCTOBER 20, 2023
He saw his brother excel at what he did, but Pratt’s life changed in 2012 when his brother was shot and killed in Chicago’s South Side. Abdullah Pratt was only ever interested in science and in sports because of his older brother Rashad.
Pharmaceutical Technology
AUGUST 2, 2024
Alemtuzumab, under the brand name Campath, was pulled from the leukaemia market by Sanofi in 2012.
STAT
NOVEMBER 18, 2023
Jennifer Doudna and Emmanuelle Charpentier, now Nobelists , published their first paper announcing a new enzyme for editing DNA in Science in June 2012. The revolution started in silence. It was called CRISPR-Cas9.
The Guardian - Pharmaceutical Industry
FEBRUARY 20, 2024
Soriot, who has made nearly £120m in the decade since he took the helm at the drugmaker in October 2012 , was paid £16.9m last year, including salary, benefits and bonuses, up from £15.3m the year before, according to AstraZeneca’s annual report. Continue reading.
STAT
SEPTEMBER 18, 2023
more than doubled from 1991 and 2012 and has continued to grow steadily in the years since. The number of credentialed midwives — including both certified nurse-midwives, who can attend births in hospital settings, and a minority of certified midwives, who don’t hold a nursing degree — in the U.S.
Therapeutics Education Collaboration
AUGUST 26, 2024
Show notes PEER Simplified Cardiovascular Decision Aid Incorporation of Shared Decision-Making in International Cardiovascular Guidelines, 2012-2022 JAMA Network Open. Show notes PEER Simplified Cardiovascular Decision Aid Incorporation of Shared Decision-Making in International Cardiovascular Guidelines, 2012-2022 […]
STAT
APRIL 10, 2024
From 2012 to 2021, Regeneron’s credit card fee reimbursements for Eylea purchases exceeded $250 million to just one of its several distributors. Continue to STAT+ to read the full story…
Pharmacy Times
MAY 22, 2023
Blasini joined FCS in 2012 as a hematopathologist and has served as co-director of the Pathology Laboratory since 2018.
STAT
SEPTEMBER 12, 2024
Designed in 2012 to encourage drug development for rare childhood diseases, the program provides vouchers to groups who get a drug in that area approved. A lifeline or a pharma handout? Either way, this program is set to expire There’s an obscure U.S. government voucher program due to sunset at the end of this month.
STAT
JULY 18, 2023
But many immigrants don’t have access to this coverage, making them more vulnerable to maternal health problems, as highlighted by a new study of nearly 73,000 postpartum people across 19 states and New York City between 2012 and 2019. Read the rest…
STAT
MAY 7, 2024
The company, which last month pleaded guilty to a misdemeanor, admitted that, from April 2012 through May 2013, some of its sales representatives marketed its medicine, also known as oxymorphone, to doctors by touting the drug as abuse deterrent, as well as resistant to tampering and crushing.
PharmD Live
MAY 30, 2024
study in the Archives of Internal Medicine found that nearly 20% of older adults on new medications experienced a prescribing cascade (Archives of Internal Medicine, 2012). New England Journal of Medicine , 365(21), 2002-2012. Impact of Polypharmacy 1. Hanlon, J., & Hajjar, E. Clinical Consequences of Polypharmacy in Elderly.
Blog: Ask a Student Pharmacist
OCTOBER 4, 2023
Minneceutics Newsletter eomizowh Wed, 10/04/2023 - 12:47 Current Newsletter Expand all + Archive 1993 1994 1995 1999 2000 2001 2002 2003 2004 2006 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
The Guardian - Pharmaceutical Industry
JANUARY 19, 2023
Hody Childress, a farmer and US air force veteran, began his anonymous charitable campaign when he walked into a drug store in his home town of Geraldine in 2012 and learned from the owner that sometimes families can’t afford to pay for their medicines. Continue reading.
STAT
MAY 22, 2023
In 2012, the United States Preventive Services Task Force convened to determine whether it should recommend kidney disease screening for all Americans. Advocates had been pushing for it, citing ballooning rates of chronic kidney disease. But at the time, the group found there wasn’t enough evidence to say if screening was a net good.
STAT
FEBRUARY 3, 2023
The drugs, a number of so-called modulators approved starting in 2012, have been one of the great biotech success stories. Continue to STAT+ to read the full story…
BioPharm
JANUARY 15, 2024
Since 2012, we’ve been the industry leader in custom mRNA synthesis for research and clinical applications. Want to increase the probability success for your discovery mRNA program? Partner with TriLink BioTechnologies®. Read on to see how TriLink® is determined to deliver you success.
STAT
NOVEMBER 3, 2022
The original guidelines , issued in 2016, helped further drive down opioid prescribing levels that had been in decline since 2012, as the country grappled with its legacy of overprescribing that contributed to the overdose epidemic.
STAT
MAY 4, 2023
Between 2012 and 2021, 14% of roughly 19,000 patent applications did not disclose financial support from the NIH or did not do so as required by federal law. And a new analysis finds a key reason may be most institutions and researchers that receive NIH support fail to fully or correctly disclose this information when applying for patents.
STAT
OCTOBER 2, 2023
” That train of thought — calculating risks, eliminating threats — eventually led her to a job with the Food and Drug Administration in 2012 as a public health analyst. And I thought, doesn’t that mean nobody should really be sliding down poles?”
STAT
MAY 9, 2023
In 2012, Ranbaxy paid a $350 million fine to U.S. As a result, the company has halted exports from the plant to the United States. At issue is a facility Sun bought eight years ago from Ranbaxy Laboratories, which was a poster child for lax manufacturing standards in India.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content